Agreed Trae, although remote, that opportunity exists for an...

Agreed Trae, although remote, that opportunity exists for an initial strike on the coy via the options. A major inst or pharma, if making a move, is more likely I think via an on market raid and cash offer. However, it would be low ball (say at 5.0c) and would not be supported by the board or major shareholders. The 30.0c sp opinion posted yesterday on the back of US Evolis success and the known known is not as far fetched as it may seem at first blush. That still would place little or no value on the Midkine IP. The clear air coming post options exercise date will finally be insightful and clarify a lot of the known unknowns.